J F Mann

Dr J F Mann, Munich General Hospitals, Ludwig Maximilians University Munchen, Germany; johannes.mann@kms.mhn.de

STUDY DESIGN

Design:

randomised controlled trial (Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial [ONTARGET]). ClinicalTrials.gov NCT00153101.

Allocation:

concealed.*

Blinding:

blinded (patients, clinicians, and {outcome assessors}†).*

STUDY QUESTION

Setting:

{733 centres in 40 countries.}†

Patients:

25 620 patients ⩾55 years of age who had established atherosclerotic vascular disease or diabetes with end-organ damage. At baseline, mean serum creatinine concentration was 94 μmol/l, mean estimated glomerular filtration rate (eGFR) was 74 ml/min/1.73 m², and mean urine albumin-to-creatinine ratio (UACR) was 0.82 mg/mmol. Exclusion criteria included major renal artery stenosis, uncorrected volume or sodium depletion, serum creatinine concentration >265 μmol/l, and uncontrolled hypertension. …